Mid-Morning Look
Thursday, November 12, 2026
|
Index |
Up/Down |
% |
Last |
|
DJ Industrials |
-0.91 |
0.00% |
52,485 |
|
S&P 500 |
-27.44 |
0.36% |
7,591 |
|
Nasdaq |
-169.21 |
0.66% |
25,296 |
|
Russell 2000 |
-27.65 |
0.97% |
2,818 |
U.S. major averages open lower, confirming the risk-off tone carried over from the premarket futures picture, as Nvidia’s leadership crisis resolved into confirmed reality this morning: Nvidia Corporation (NVDA) announced that CEO Jensen Huang has resigned effective immediately, with CFO Colette Kress named interim CEO and Harvey C. Jones installed as the board’s first-ever chair. NVDA shares extending losses after a tumultuous week (taking out 52-week lows of $164.27 in March) as Jensen Huang resigns as President, CEO, and board member effective immediately. The news comes after a head-spinning week of news and allegations around CEO Jensen Huang that included an extra martial affair with Alice Huang, CEO of Nvidia customer Megaspeed and (allegedly) a possible Intelligence asset for China. Also last night the issues broadened with the New York Times reporting that Mr. Huang had an affair with a direct report (allegedly Kimberly Powell, the company’s VP of Healthcare). The board acted quickly this morning. In other AI news, neocloud company NBIS shares tumbled around -20% in the neocloud sector after posted big quarterly beat across the board, but said they are doing away with ARR reporting, after posting lighter than expected revenue guidance (trimming ARR guidance to exceed $7B for the month of February 2027, down from prior $7-$9B by December 2026), while they also raised capex (to $40B-$45B from estimate $28.9B). The pullback comes after good news in the space yesterday after CRWV results. Investors rotating back int defensive sectors with Utilities, Healthcare and Consumer names rising. Bitcoin prices down again today, falling -4% to $71,320 and on track for its 6th straight weekly decline; not helped by weakness in MSTR as shares fall -7% after index operator MSCI confirmed that it will remove the company from its Benchmark equity indexes as part of its November 2026 review. Treasury yields jumping again as the 10-yr rises 7 bps to 5.06% (dragging down Smallcaps and other interest rate sensitive names), while oil prices rebound on a Trump Truth Social post stating: “We don’t need a deal with Iran. Those days have long since passed.” Precious metals prices tumble as December gold down 3.22% to $3,871 an ounce
Economic Data
- Weekly Jobless Claims climbed to 200,000 from 191,000 prior and vs. consensus 195,000; the 4-week moving average was unchanged at 195,250 in latest week; continued claims fell to 1.697M Oct 31 week (con. 1.710M) from 1.717M prior week (prev 1.718M).
- Oct Existing Home Sales fell -5.5% to 3.75M unit rate below consensus 3.85M and compared to Sept 3.97M reading; Oct National median home price for existing homes $416,700, +0.4% from Oct 2025; U.S. Oct inventory of homes for sale 1.59M units, 5.1 months’ worth.
|
Macro |
Up/Down |
Last |
|
WTI Crude |
0.23 |
86.78 |
|
Brent |
1.02 |
93.78 |
|
Gold |
-128.70 |
3,871.80 |
|
EUR/USD |
-0.0023 |
1.1067 |
|
JPY/USD |
0.22 |
159.93 |
|
10-Year Note |
0.07 |
5.06% |
Sector Movers Today
- Semiconductor sector (SOX) along with data centers, opticals and AI infrastruture names all impacted by the NVDA headlines and NBIS guidance. NVDA dominates the headlines, downgraded by at least five Wall Street analysts (OPCO, Evercore, Keybanc, William Blair and Bernstein) after a head-spinning week of news and allegations around CEO Jensen Huang, and reports overnight that Nvidia’s board is reportedly preparing to remove him, according to the Wall Street Journal. Press stories over the weekend reported on NVDA CEO Jensen Huang’s indiscretions with Alice Huang, CEO of Nvidia customer Megaspeed and (allegedly) a possible Intelligence asset for China. Last night the issues broadened with the New York Times reporting that Mr. Huang had an affair with a direct report (allegedly Kimberly Powell, the company’s VP of Healthcare), followed by a WSJ report suggesting the co is preparing to oust him.
- Metals & Mining: another rough day for shares of precious metal miners (B, CDE, AEM, NEM, HL, PAAS, WPM) with gold and silver prices falling again following the recent Hawkish Fed shift given hotter CPI inflation data earlier in the week raised prospects of a 25bps rate hike in December to almost 100% and now has a 50bps hike potentially now on the table. In steel, CLF was upgraded from Underweight to Equal Weight with $15 tgt at Barclays given the significant increase to its 2027/28 estimates following its Steel-price forecast revisions. RS was upgraded to Overweight at Barclays as well with raised tgt to $507 and upped the company’s 2027 and 2028 estimates on expectations will continue to benefit from a tight supply environment.
- Specialty retail: YETI shares fell after posted Q3 adj ES beat but revs of $509.4M rose 4% y/y but missed the estimate of $523M and lowered its adjusted sales growth forecast to about 6% from prior view of 7%-8% previously and lowers top/bottom end of 2026 adj EPS view; says consumer environment will remain cautious and pressure demand in Q4. SPB says it remains optimistic on pursuing HELE after its subsidiary Empower Brands’ buyout interest was rejected last week, calling itself disappointed by the rejection. posted Q4 adjusted EPS of $1.39, topping consensus of $0.90, on revenue of $713.2 million that missed estimates of $719.6 million.
Stock GAINERS
- AMD +2%; shares continue to rise A9long with AVGO) as NVDA shares fall, seen as beneficiaries to the NVDA drama. William Blair upgraded AMD to Outperform saying while Nvidia is facing increased scrutiny and a potential leadership vacuum, they sees an opportunity for AMD to benefit from custom programs as an opportunity for CPU attach.
- LLY +1%; became the first drugmaker to have a GLP-1 weight-loss pill approved in China, giving it an edge over rival NVO China has until now only approved GLP-1 medications for weight management in the form of injection
- LUNR +13%; Q3 revenue of $269.3M beats estimate of $245.9M and smaller Q3 net loss (-$0.02) vs. est. loss (-$0.11) and posted record backlog of $1.9B at end of Q3, up from $213M at end of 2025 while guides FY26 revenue view to $920M-$950M from $900M-$1B.
- SPB +4%; says it remains optimistic on pursuing HELE after its subsidiary Empower Brands’ buyout interest was rejected last week, calling itself disappointed by the rejection; posted Q4 adjusted EPS of $1.39, topping consensus of $0.90.
- TRMK +6%; as HWC to acquire TRMK in all-stock deal valued at $3.20B as deal expected to be 7% accretive to Hancock Whitney’s 2028 estimated EPS. Trustmark shareholders to receive 0.7463 Hancock Whitney shares per Trustmark share.
- TTEK +9%; shares jumped after reported Q4 above estimate with beat driven by DOS revenue while FY27 guidance is modestly ahead with NSR guidance of 4% y/y
Stock LAGGARDS
- CDNL -58%; after results as posts Q3 gross margin of 5.4%, down from 15.9% Y/y, withdraws previously issued FY26 revenue and adj. EBITDA margin forecast and postpones proposed acquisition with Hughes Brothers, a heavy civil and site development contractor.
- CTVA -23%; cut its FY26 adj. EPS forecast to $0.76-$0.80, below consensus $1.64 and down from the prior range of $3.60-$3.80, driven by challenges in Brazil, including elevated inventory, delayed purchases and high interest rates, leading to a 31% decline in Latin America organic sales.
- ENVX -20%; after the company reported a Y/y decrease in its Q3 adjusted EPS result; announced it decided not to proceed with system-level field testing using the pre Ai-2 units; guided FY27 sales $65M-$85M missing the $77.83M consensus.
- KDP -5%; said it has commenced an underwritten public offering for $2 billion worth of shares of its common stock.
- MSTR -6%; after index operator MSCI confirmed Wednesday that it will remove the company from its Benchmark equity indexes as part of its November 2026 review.
- NBIS -19%; Q3 revs $980.9M topped the $907.5M consensus and projected $12B-$13B in sales for 2027; However, its 2026 revenue forecast range of $3B-$3.4B was slightly lower than market estimates of $3.37B at the midpoint and trims ARR guidance in Feb to $7B (prior $7B-$9B view).
- NVDA -5%; downgraded by at least five Wall Street analysts (OPCO, KeyBanc, Evercore, William Blair and Bernstein) after a head-spinning week of news and allegations around CEO Jensen Huang, and reports overnight that Nvidia’s board is reportedly preparing to remove him following reports of a second extra martial affair with a direct report.
- OPRX -25%; as revenue down 18% y/y reflecting known headwinds with LTM NRR falling to 83% versus 90% in 2Q, the lowest level since that metric has been reported (known large client spend reduction beginning 1Q26); cuts FY26 revenue $87M-$93M, from $95M-$100M.
- PEPG -2%; after pricing 25M shares of stock at $5.00 – the move comes after shares surged over 90% on stronger-than-expected mid-stage trial results for its experimental drug, PGN-EDODM1, for myotonic dystrophy type 1.
- YETI -8%; shares fell after posted Q3 adj ES beat but revs of $509.4M rose 4% y/y but missed the estimate of $523M and lowered its adjusted sales growth forecast to about 6% from prior view of 7%-8% previously and lowers top/bottom end of 2026 adj EPS view.
Market commentary provided by Hammerstone Markets, Inc, a firm separate from and not affiliated with Regal Securities. Regal Securities has not participated in the creation of the content, and does not explicitly or implicitly endorse the content.